Literature DB >> 3795287

Dissemination of prostatic carcinoma: an autopsy study.

F Lamothe, J Kovi, M Y Heshmat, E J Green.   

Abstract

Autopsy protocols at Howard University Hospital (HUH), Washington, DC, for the period of 1930 to 1985 were reviewed. The patient population of the hospital is predominantly black. Necropsy cases with adenocarcinoma of the prostate were tabulated according to the presence or absence of metastasis and the site of the metastatic lesion. A comparison was made with a similar racially unselected (predominantly white) series (Massachusetts General Hospital).The most commonly involved organs by secondary carcinoma of the prostate were, in descending order of frequency, lymph nodes, bones, bladder, lung, liver, and kidneys. In comparison with the MGH unselected series, the distribution of metastatic sites was significantly different (P < .0001). In the HUH series, kidney and adrenal gland metastases were more common than in the control series. The seminal vesicles were more frequently involved in the MGH series. In the HUH series, 76 percent of bone metastases occurred in the vertebrae, while the comparable figure for the MGH series was 40 percent.

Entities:  

Mesh:

Year:  1986        PMID: 3795287      PMCID: PMC2571425     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  8 in total

1.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES.

Authors:  O V Batson
Journal:  Ann Surg       Date:  1940-07       Impact factor: 12.969

2.  Cancer statistics. 1986.

Authors:  E Silverberg
Journal:  CA Cancer J Clin       Date:  1986 Jan-Feb       Impact factor: 508.702

3.  Mechanisms of cancer metastasis to bone.

Authors:  B A Berrettoni; J R Carter
Journal:  J Bone Joint Surg Am       Date:  1986-02       Impact factor: 5.284

4.  Incidence of cancer in negroes in Washington, D.C. and selected African cities.

Authors:  J Kovi; M Y Heshmat
Journal:  Am J Epidemiol       Date:  1972-12       Impact factor: 4.897

5.  Patterns of progression in prostate cancer.

Authors:  J E McNeal; D G Bostwick; R A Kindrachuk; E A Redwine; F S Freiha; T A Stamey
Journal:  Lancet       Date:  1986-01-11       Impact factor: 79.321

6.  Prostatic cancer: mortality and incidence rates by race and social class.

Authors:  V L Ernster; S Selvin; S T Sacks; D F Austin; S M Brown; W Winkelstein
Journal:  Am J Epidemiol       Date:  1978-04       Impact factor: 4.897

7.  Unusual metastatic patterns of prostate adenocarcinoma.

Authors:  D D Venable; D Hastings; R P Misra
Journal:  J Urol       Date:  1983-11       Impact factor: 7.450

8.  The dissemination of cancer by transurethral resection of locally advanced prostate cancer.

Authors:  G E Hanks; S Leibel; S Kramer
Journal:  J Urol       Date:  1983-02       Impact factor: 7.450

  8 in total
  4 in total

1.  Liver protects metastatic prostate cancer from induced death by activating E-cadherin signaling.

Authors:  Bo Ma; Sarah E Wheeler; Amanda M Clark; Diana L Whaley; Min Yang; Alan Wells
Journal:  Hepatology       Date:  2016-09-23       Impact factor: 17.425

2.  Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation.

Authors:  Evyn G Arnfield; Paul A Thomas; Matthew J Roberts; Anita M Pelecanos; Stuart C Ramsay; Charles Y Lin; Melissa J Latter; Peter L Garcia; David A Pattison
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-16       Impact factor: 9.236

3.  Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis.

Authors:  Pietro Ghedini; I Bossert; L Zanoni; F Ceci; T Graziani; P Castellucci; V Ambrosini; F Massari; E Nobili; B Melotti; A Musto; S Zoboli; L Antunovic; M Kirienko; A Chiti; C Mosconi; A Ardizzoni; R Golfieri; S Fanti; C Nanni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-30       Impact factor: 9.236

4.  Peritoneal dissemination of prostate cancer with the absence of lymph node, skeletal, or visceral metastases in a patient scheduled to undergo robot-assisted radical prostatectomy.

Authors:  Apostolos P Labanaris; Vahudin Zugor; Sasa Pokupic; Samir Afram; Jorn H Witt
Journal:  J Robot Surg       Date:  2012-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.